Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DONANEMAB-AZBT Cause Headache? 111 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Headache have been filed in association with DONANEMAB-AZBT. This represents 10.9% of all adverse event reports for DONANEMAB-AZBT.

111
Reports of Headache with DONANEMAB-AZBT
10.9%
of all DONANEMAB-AZBT reports
1
Deaths
16
Hospitalizations

How Dangerous Is Headache From DONANEMAB-AZBT?

Of the 111 reports, 1 (0.9%) resulted in death, 16 (14.4%) required hospitalization, and 2 (1.8%) were considered life-threatening.

Is Headache Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DONANEMAB-AZBT. However, 111 reports have been filed with the FAERS database.

What Other Side Effects Does DONANEMAB-AZBT Cause?

Amyloid related imaging abnormality-oedema/effusion (185) Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits (139) Infusion related reaction (97) Amyloid related imaging abnormalities (80) Flushing (68) Cerebral haemorrhage (54) Dizziness (48) Nausea (44) Cerebral microhaemorrhage (41) Confusional state (40)

What Other Drugs Cause Headache?

ADALIMUMAB (19,891) APREMILAST (17,024) ETANERCEPT (14,253) TREPROSTINIL (14,051) METHOTREXATE (11,718) TOFACITINIB (11,061) RITUXIMAB (8,747) TOCILIZUMAB (8,448) INFLIXIMAB (8,387) ABATACEPT (8,184)

Which DONANEMAB-AZBT Alternatives Have Lower Headache Risk?

DONANEMAB-AZBT vs DONEPEZIL DONANEMAB-AZBT vs DONEPEZIL\DONEPEZIL DONANEMAB-AZBT vs DONEPEZIL\MEMANTINE DONANEMAB-AZBT vs DONEPEZIL\OMEPRAZOLE\OMEPRAZOLE DONANEMAB-AZBT vs DONOR HUMAN STOOL

Related Pages

DONANEMAB-AZBT Full Profile All Headache Reports All Drugs Causing Headache DONANEMAB-AZBT Demographics